Brought to you by:
SCVS 2025: TBE device provides ‘safer’ option than TEVAR for blunt thoracic injuries in setting of zone 2 coverage
Use of the Gore Tag thoracic branch endoprosthesis (TBE) “offers a safer alternative” to traditional thoracic endovascular aortic repair (TEVAR) with left subclavian artery (LSA) coverage in blunt thoracic aortic injury (BTAI) requiring zone 2 coverage for zone 2 or…
Insights from the GREAT registry: ‘We have achieved freedom from aortic-related mortality in just over 95% of patients’
Dennis Gable, MD, from The Heart Hospital Baylor Plano in Plano, Texas, discusses the unique imprint of the five-year follow-up from the GREAT registry and analyses the results in patients with aortic dissection. “We have just over 97% of patients…
Insights from the GREAT registry: ‘We had a follow-up of over 95% for all patients’
Dennis Gable, MD, from The Heart Hospital Baylor Plano in Plano, Texas, principal investigator for the thoracic component of the GREAT registry, explains that this is a real-world evaluation of use of WL Gore’s aortic products in the abdomen and…
The top 10 most popular Vascular Specialist stories of June 2024
In June, the most read stories from Vascular Specialist included key reports from the 2024 Vascular Annual Meeting (VAM; June 19–22) covering TEVAR, CEA vs TCAR, PAD and CFA-reintervention, among others; Linda Harris’ placement as SVS vice president; the relationship…
Gore announces first commercial implant of Gore Tag thoracic branch endoprosthesis in Canada
Gore has announced the first commercial use of the Gore Tag thoracic branch endoprosthesis (TBE) in Canada. The news came as Canadian government health authority Health Canada approved the first-of-its-kind endovascular device, which is indicated to treat lesions of the…
VAM 2024: Paper exploring stroke rates in arch TEVAR emerges as winner of Poster Competition
The 2024 Vascular Annual Meeting (VAM) in Chicago showcased emerging talent in vascular surgery through a moderated Poster Competition held over two days of the conference. This event provided a platform for research and recognized excellence among the next generation…
SAVS makes travel scholarship applications call for 2024 meeting
The Southern Association for Vascular Surgery (SAVS) has put out a call for applications from medical students and general surgery residents for 20 travel scholarships now available to attend the 2024 SAVS annual meeting. Applicants must be either a medical…
Breaking ground: A trial to improve the care of uncomplicated type B aortic dissection
Because high-quality evidence from large, prospective multicenter trials on the best treatment of uncomplicated type B aortic dissection (uTBAD) is scarce, SVS members Firas F. Mussa, MD, a professor of vascular surgery at UT-Houston in Houston, Texas, and Panos Kougias,…
Study finds no correlation between TEVAR timing and uncomplicated type B aortic dissection outcomes
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective of the timing of treatment after dissection. This is according to a study recently published in…
NESVS 2022: Study illustrates relationship between increased distance from medical center and higher treatment costs among complex aortic patients
Research detailing that patients traveling farther for complex aortic surgery have higher procedural costs, postoperative imaging costs, and comprehensive one-year costs was among the new science being presented at the 2022 annual meeting of the New England Society for Vascular…